Press release
Antibody-drug Conjugates Market Analysis Share, Growth and Application Analysis To 2022
This report analyzes the Global Antibody-drug Conjugates Market and gives us the in-depth analysis of the present scenario and the future growth prospects. Simultaneously it also throws light on the overall positive factors. The global market for antibody drug conjugates is expected to be driven by the advancement in medical technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antibody-drug Conjugates in these regions, from 2012 to 2022 (forecast), covering like North America, Europe, China, Japan, Southeast Asia, India.
Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-antibody-drug-conjugates-market-research-report-2017-d-229
Global Antibody-drug Conjugates market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including:
ImmunoGen
Seattle Genetics
Roche
Takeda
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into:
Adcetris
Kadcyla
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including:
Breast Cancer
Lymphoma
Browse full report at: https://www.qyresearchreports.us/market-analysis/global-antibody-drug-conjugates-market-research-report-2017-d-229
Table of Contents -
1 Antibody-drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugates
1.2 Antibody-drug Conjugates Segment by Type (Product Category)
1.2.1 Global Antibody-drug Conjugates Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Antibody-drug Conjugates Production Market Share by Type (Product Category) in 2016
1.2.3 Adcetris
1.2.4 Kadcyla
1.3 Global Antibody-drug Conjugates Segment by Application
1.3.1 Antibody-drug Conjugates Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugates Market by Region (2012-2022)
1.4.1 Global Antibody-drug Conjugates Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Antibody-drug Conjugates (2012-2022)
1.5.1 Global Antibody-drug Conjugates Revenue Status and Outlook (2012-2022)
1.5.2 Global Antibody-drug Conjugates Capacity, Production Status and Outlook (2012-2022)
…
7 Global Antibody-drug Conjugates Manufacturers Profiles/Analysis
7.1 ImmunoGen
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Antibody-drug Conjugates Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 ImmunoGen Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Seattle Genetics
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Antibody-drug Conjugates Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Seattle Genetics Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Roche
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Antibody-drug Conjugates Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Roche Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Takeda
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Antibody-drug Conjugates Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Takeda Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
...
About Us:
QYResearchReports.us is your exclusive destination for the entire spectrum of Market Research and Business Solutions. Depending upon the clients, we provide customized as well as syndicated reports. Our market intelligence covers industries like technology, food and beverages, chemical materials, pharmaceuticals and healthcare, agriculture, consumer goods, among others. Irrespective of your business’s state as of today, we have a team of industry specific experts who will provide tailor-made market research surveys and solutions.
Contact us:
Email - sales@qyresearchreports.us
Web - https://www.qyresearchreports.us
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody-drug Conjugates Market Analysis Share, Growth and Application Analysis To 2022 here
News-ID: 859388 • Views: …
More Releases from qyresearchreports.us

SUV Ignition Coil Market Supply & Demand Research Report 2017
QY Research Reports analysts estimate the SUV Ignition Coil Market to grow at a substantial CAGR during the forecast period 2017 to 2022.
In this report, the global SUV Ignition Coil market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions,…

Fistula Needles Market to See Strong Application Scope Globally from 2017 to 202 …
QY Research Reports analysts estimate the Fistula Needles Market to grow at a substantial CAGR during the forecast period 2017 to 2022.
This report studies Fistula Needles in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-fistula-needles-market-professional-survey-report-2017-d-1963
This report focuses on top manufacturers…

Pen Needles Market Report for Period 2017 till 2022
QY Research Reports analysts estimate the Pen Needles Market to grow at a substantial CAGR during the forecast period 2017 to 2022.
This report studies Pen Needles in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-pen-needles-market-professional-survey-report-2017-d-1961
This report focuses on top manufacturers…

Biopsy Needles Market Demand Growth Analysis 2017 To 2022
QY Research Reports analysts estimate the Biopsy Needles Market to grow at a substantial CAGR during the forecast period 2017 to 2022.
This report studies Biopsy Needles in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-biopsy-needles-market-professional-survey-report-2017-d-1959
This report focuses on top manufacturers…
More Releases for Conjugates
Global Cancer Antibody Drug Conjugates Market
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions:
• Global Cancer Antibody Drug Conjugates Market: 2020 - 2030
• Global Cancer Antibody Drug Conjugates Market Opportunity > US$ 50 Billion By 2030
• Approved Cancer Antibody Drug Conjugates: 16 Drugs
• Approved Cancer Antibody Drug Conjugates Sales Insights, Patent, Dosage and Price Analysis
• Cancer Antibody Drug Conjugates In Clinical Trials: > 500 Drugs
• Cancer Antibody Drug Conjugates Clinical…
Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,…
DLL3 Antibody-Drug Conjugates: Mechanisms and Efficacy
Antibody-drug conjugates (ADCs) represent a revolutionary approach in cancer treatment, combining the targeting capabilities of antibodies with the cytotoxic power of chemotherapy. DLL3 (Delta-Like Ligand 3) has emerged as a promising target for ADCs, particularly in the treatment of small cell lung cancer (SCLC) and other neuroendocrine tumors. This article explores the mechanisms and efficacy of DLL3 ADCs, shedding light on their potential in modern oncology.
Download Report:
https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor
DLL3 is a…
Radionuclide Drug Conjugates (RDC) Market Minimizing Side Effects, Maximizing Im …
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Oncology Antibody Drug Conjugates Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is projected to grow from USD 9.87 billion in 2022 to USD 22.48 billion at a CAGR value of 12.4% from 2022 to 2027.
Pfizer Inc., Astellas Pharma Inc., Gilead Sciences, Inc., GlaxoSmithKline, F. Hoffmann-La Roche AG, Daiichi Sankyo, AstraZeneca, Sanofi, AbbVie, Merck & Co., Byondis, RemeGen, ImmunoGen, Seagen, Rakuten Medical,…
Global Antibody Drug Conjugates Market Insights, Forecast
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement…